Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00404066
Status:
COMPLETED
Last Update Posted:
2017-12-22
First Post:
2006-11-22
Brief Title:
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide - Docetaxel With Lapatinib in Stage IIIII Her2Neu Breast Cancer
Sponsor:
Organization:
Stanford University